1021950-19-5Relevant academic research and scientific papers
HYDANTOIN DERIVATIVE
-
Paragraph 0679, (2021/03/13)
A compound represented by general formula (I-a) : has a strong DDR1 inhibitory activity, and can be a therapeutic agent for DDR1-related diseases, for example, a cancer, a kidney disease, a cardiovascular disease, a central nervous system disease, or fibrosis.
NOVEL COMPOUNDS
-
Page/Page column 40, (2008/12/05)
The present invention relates to compounds of formula (I): and processes for preparing them, compositions containing them and their use in treating diseases relating to inappropriate c-Met activity.
